Impact and safety of chimeric antigen receptor T cell therapy in vulnerable older patients with relapsed/refractory diffuse large B-cell lymphoma Meeting Abstract

  

Authors:	Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, J. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Mead, E.; Noy, A.; Palomba, M. L.; Santomasso, B.; Sauter, C. S.; Scordo, M.; Shah, G. L.; Korc-Grodzicki, B.; Kim, S. J.; Silverberg, M. L.; Brooklyn, C. A.; Devlin, S. M.; Perales, M. A.
Abstract Title:	Impact and safety of chimeric antigen receptor T cell therapy in vulnerable older patients with relapsed/refractory diffuse large B-cell lymphoma
Meeting Title:	61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	134
Issue:	Suppl. 1
Meeting Dates:	2019 Dec 7-10
Meeting Location:	Orlando, FL
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2019-11-13
Language:	English
ACCESSION:	WOS:000577160402155
DOI:	10.1182/blood-2019-125162
PROVIDER:	wos
Notes:	Meeting Abstract: 1603 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/175705